Skip to main content
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.58
+0.75 (6.93%)
At close: Jan 21, 2025, 4:00 PM
11.63
+0.05 (0.43%)
After-hours: Jan 21, 2025, 7:13 PM EST

Ginkgo Bioworks Holdings Revenue

Ginkgo Bioworks Holdings had revenue of $89.05M in the quarter ending September 30, 2024, with 60.65% growth. This brings the company's revenue in the last twelve months to $217.95M, down -30.81% year-over-year. In the year 2023, Ginkgo Bioworks Holdings had annual revenue of $251.46M, down -47.36%.

Revenue (ttm)
$217.95M
Revenue Growth
-30.81%
P/S Ratio
2.70
Revenue / Employee
$178,942
Employees
1,218
Market Cap
614.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings

DNA News

More News